Central 5-Hydroxytryptaminergic Function in Irritable Bowel Syndrome

References

• Chaudhary N A, Truelove SC. The irritable colon syndrome. Q J Med 1962; 31: 307–22
   PubMedGoogle Scholar
• Drossman D A, Sandier R S, Mc Kee D C, Lovitz AJ. Bowel patterns among subjects not seeking health care. Gastroenterology 1982; 83: 529–34
   PubMed Web of Science ®Google Scholar
• Sandier R S, Drossman D A, Nathan H P, McKee DC. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology 1984; 87: 314–8
   PubMed Web of Science ®Google Scholar
• Kumar D, Wingate DL. The irritable bowel syndrome: a paroxysmal motor disorder. Lancet 1985; 2: 973–7
   PubMed Web of Science ®Google Scholar
• Hislop IG. Psychological significance of the irritable colon syndrome. Gut 1971; 12: 452–7
   PubMed Web of Science ®Google Scholar
• Creed F, Guthrie E. Psychological factors in the irritable bowel syndrome. Gut 1987; 28: 1307–18
   PubMed Web of Science ®Google Scholar
• Blanchard E B, Scharff L, Schwarz S P, Suls J M, Barlow DH. The role of anxiety and depression in the irritable bowel syndrome. Behav Res Ther 1990; 28: 401–5
   PubMed Web of Science ®Google Scholar
• Walker E A, Roy-Byrne P P, Katon W J, Li L, Amos D, Jiranek G. Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease. Am J Psychiatry 1990; 147: 1656–61
   PubMed Web of Science ®Google Scholar
• Craig T KJ, Brown GW. Goal frustration and life events in the aetiology of painful gastrointestinal disorder. J Psychosom Res 1984; 28: 411–21
   PubMed Web of Science ®Google Scholar
• Whitehead W E, Crowell M D, Robinson J C, Heller B R, Schuster MM. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut 1992; 33: 825–30
   PubMed Web of Science ®Google Scholar
• Quattrone A, Tedeschi G, Aguglia U, Scopacasa F, Di Renzo G F, Annunziato L. Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine. Br J Clin Pharmacol 1983; 16: 471–5
   PubMed Web of Science ®Google Scholar
• Siever L J, Murphy D L, Slater S, De la Vega E, Lipper S. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. Life Sci 1984; 34: 1029–39
   PubMed Web of Science ®Google Scholar
• Coccaro E F, Siever L J, Klar H M, Maurer G, Cochrane K, Cooper T B, et al. Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry 1989; 46: 587–99
   PubMed Web of Science ®Google Scholar
• Coppen A, Prange A J, Whybrow P C, Noguera C. Abnormalities of indoleamines in affective disorders. Arch Gen Psychiatry 1972; 26: 474–8
   PubMed Web of Science ®Google Scholar
• Dinan T G, Yatham L N, Barry S, Chua A, Keeling P WN. Serotonin supersensitivity: the pathophysiologic basis of non-ulcer dyspepsia?. Scand J Gastroenterol 1990; 25: 541–4
   PubMed Web of Science ®Google Scholar
• Chua A, Keating J, Hamilton D, Keeling P WN, Dinan TG. Central serotonin receptors and delayed gastric emptying in non-ulcer dyspepsia. Br Med J 1992; 305: 280–2
   PubMed Web of Science ®Google Scholar
• Invernizzi R, Berettera C, Garattini S, Samanin R. D- and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. Eur J Pharmacol 1986; 120: 9–15
   PubMed Web of Science ®Google Scholar
• Garattini S, Bizzi A, Caccia S, Mennini T, Samanin R. Progress in assessing the role of serotonin in the control of food intake. Clin Neuropharmacol 1988; 11: S8–32, Suppl 1
   PubMed Web of Science ®Google Scholar
• Gorard D A, Taylor T M, Medbak S H, Perry L A, Libby G W, Farthing M JG. Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects. Int Clin Psychopharmacol 1993; 8: 123–8
   PubMed Web of Science ®Google Scholar
• O'Keane V, Dinan TG. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. Am J Psychiatry 1991; 148: 1009–15
   PubMed Web of Science ®Google Scholar
• Thompson W G, Dotevall G, Drossman D A, Heaton K W, Kruis W. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol Int 1989; 2: 92–5
   Google Scholar
• Cunnah D, Jessops D S, Besser G M, Rees LH. Measurement of circulating corticotrophin releasing factor in man. J Endocrinol 1987; 113: 123–31
   PubMed Web of Science ®Google Scholar
• Acharya U, Waite N, Howlett P, Tanner A R, Smith CL. Failure to demonstrate altered gastric emptying in irritable bowel syndrome. Dig Dis Sci 1983; 28: 889–92
   PubMed Web of Science ®Google Scholar
• Horowitz M, Maddox A, Wishart J, Vernon-Roberts J, Chatterton B, Shearman D. Effect of dexfenfluramine on gastric emptying of a mixed solid-liquid meal in obese subjects. Br J Nutrition 1990; 63: 447–55
   PubMed Web of Science ®Google Scholar
• Debbas N MG, Ings R MJ, Gordon B H, Richards R P, Jackson S HD, Turner P. (+)-fenfluramine: relative and absolute bioavailability of a solution compared with a capsule. Br J Clin Pharmacol 1985; 20: 549P
   Web of Science ®Google Scholar
• Zigmond A S, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361–70
   PubMed Web of Science ®Google Scholar
• Beck A T, Ward C H, Mendelson M, Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561–71
   PubMed Web of Science ®Google Scholar
• Spitzer R L, Williams J BW, Gibbon M, First MB. Structured clinical interview for DSM-III-R: non-patient edition (SCID-NP). American Psychiatric Press, Washington, DC 1990
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-III-R).3rd ed. rev. American Psychiatric Association, Washington, DC 1987
   Google Scholar
• Di Renzo G, Amoroso S, Taglialatela M, Canzoniero L, Basile V, Fatatis A, et al. Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion. Eur J Pharmacol 1989; 162: 371–3
   PubMed Web of Science ®Google Scholar
• Meltzer H Y, Flemming R, Robertson A. The effect of buspirone on prolactin and growth hormone secretion in man. Arch Gen Psychiatry 1983; 40: 1099–102
   PubMed Web of Science ®Google Scholar
• Fuller RW. Serotonergic stimulation of pituitary-adrenocortical function in rats. Neuroendocrinology 1981; 32: 118–27
   PubMed Web of Science ®Google Scholar
• Gomborone J E, Dewsnap P A, Libby G W, Farthing M JG. Influence of psychiatric morbidity on self-appraisal of symptoms in irritable bowel syndrome. Gut 1993; 34: S56, Suppl 1
   PubMedGoogle Scholar
• Heaton K W, Ghosh S, Braddon F EM. How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. Gut 1991; 32: 73–9
   PubMed Web of Science ®Google Scholar
• Hardo P G, Jones S C, Axon A TR, Chalmers DM. The sleep disturbance of the irritable bowel syndrome: relationship to anxiety, depression and pain. Proceedings of IInd United European Gastroenterology Week 1993; A-207, abstract
   Google Scholar
• Andrews H, Barczak P, Allan RN. Psychiatric illness in patients with inflammatory bowel disease. Gut 1987; 28: 1600–4
   PubMed Web of Science ®Google Scholar
• Magni G, Bernasconi G, Mauro P, D'Odorico A, Sturniolo G C, Canton G, et al. Psychiatric diagnoses in ulcerative colitis. A controlled study. Br J Psychiatry 1991; 158: 413–5
   PubMed Web of Science ®Google Scholar
• Lucey J V, O'Keane V, Butcher G, Clare A W, Dinan TG. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls. Br J Psychiatry 1992; 161: 517–21
   PubMed Web of Science ®Google Scholar
• O'Keane V, Moloney E, O'Neill H, O'Connor A, Smith C, Dinan TG. Blunted prolactin responses to d-fenfluramine in sociopathy. Br J Psychiatry 1992; 160: 643–6
   PubMed Web of Science ®Google Scholar
• Gold P W, Loriaux D L, Roy A, Kling M A, Calabrese J R, Kellner C H, et al. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. N Engl J Med 1986; 314: 1329–35
   PubMed Web of Science ®Google Scholar
• Dinan T G, Barry S, Ahkion S, Chua A, Keeling P WN. Assessment of central noradrenergic functioning in irritable bowel syndrome using a neuroendocrine challenge test. J Psychosom Res 1990; 34: 575–80
   PubMed Web of Science ®Google Scholar